PA-21-219 - Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional)
PA-18-358 - NINDS Exploratory Neuroscience Research Grant (R21- Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Mental Health (NIMH)
The NINDS and the NIMH plan to publish a re-issue of the R21 Funding Opportunity Announcement (FOA), PA-18-358 - NINDS Exploratory Neuroscience Research Grant (R21- Clinical Trial Optional).
It is anticipated that the re-issue will be published to accommodate the June 16th standard R21 receipt date. This Notice of Intent to Publish (NOITP) is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.
Only applications that fall within the scientific mission of the NINDS or the NIMH Strategic Plan Goal 1 or NIMH Division of AIDS Research HIV Neuropathogenesis, Genetics, and Therapeutics Branch will be considered for funding via this FOA. To assess the relevance of an application topic, applicants are strongly encouraged to contact NINDS or NIMH program staff before submitting. A listing of NINDS program staff can be found at: https://www.ninds.nih.gov/About-NINDS/Who-We-Are/Program-Directors. NIMH programs and contacts can be found at https://www.nimh.nih.gov/about/organization/extramural-programs-and-contacts-listed-by-contact-name.shtml.
The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Direct costs are limited to $275,000 over a two-year period, with no more than $200,000 in direct costs allowed in any single year.
Applications are not being solicited at this time.
Please direct all inquiries to: